The FDA has now resolved the shortages of Novo Nordisk’s and Eli Lilly’s blockbuster weight-loss drugs, which could spell the ...
The ruling shows Novo Nordisk’s confidence that the supply of semaglutide will be stable for now.
The semaglutide shortage has officially ended in the US—which means the GLP-1 drug industry is about to undergo massive ...
The FDA says the nationwide shortage for Ozempic and Wegovy is over, but as CBS News New York's Ali Bauman explains, that supply change could lead to consumers paying more.
1d
Medpage Today on MSNOzempic, Wegovy Shortage Is Officially OverThe shortage of semaglutide injections (Ozempic, Wegovy) is over, the FDA announced on Friday. The agency, along with maker ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results